<!DOCTYPE html>
<html lang="ja" prefix="og: http://ogp.me/ns#">

<head>
    <meta charset="utf-8">
    <meta name="viewport" content="width=device-width, initial-scale=1">
    <meta name="description" content="BIOMOD">
    <title>ELSI | TEAM TOKYOTECH</title>
    <!-- Google Font -->
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:ital,opsz,wght@0,14..32,100..900;1,14..32,100..900&family=Montserrat:ital,wght@0,700;1,700&family=Noto+Sans:ital,wght@0,100..900;1,100..900&family=Open+Sans:ital,wght@0,300..800;1,300..800&family=Sen:wght@400..800&family=Sorts+Mill+Goudy:ital@0;1&display=swap" rel="stylesheet">
    <link href="https://cdnjs.cloudflare.com/ajax/libs/font-awesome/6.5.2/css/all.min.css" rel="stylesheet">
    <!-- CSS -->
    <link rel="stylesheet" href="https://t2biomod2024.github.io/2024/css/common_css/bootstrap.min.css">
    <link rel="stylesheet" href="https://t2biomod2024.github.io/2024/css/parts_css/header.css">
    <link rel="stylesheet" href="https://t2biomod2024.github.io/2024/css/parts_css/footer.css">
    <link rel="stylesheet" href="https://t2biomod2024.github.io/2024/css/parts_css/accordion.css">
    <link rel="stylesheet" href="https://t2biomod2024.github.io/2024/css/common_css/loading.css">
    <link rel="stylesheet" href="https://t2biomod2024.github.io/2024/css/common_css/template.css"> 
    <!-- Icon -->
    <link rel="icon" href="https://t2biomod2024.github.io/2024/pics/logo_black.PNG">
</head>

<body>

    <div id="container">

        <aside id="sub-mainimg">
            <h2>ELSI</h2>
        </aside>

        <div id="contents">
        <main>
        <div class="shapedividers_com-1753"></div>
        <section class="topic-section">            
            <div class="topic-title"><h3>Importance of ELSI</h3></div>
                <h4>What is ELSI?</h4>
                    <p>&nbsp;&nbsp;&nbsp;&nbsp;ELSI stands for "Ethical, Legal, and Social Issues/Implications," and is a concept that is gaining attention in fields such as biotechnology and emerging technologies. As technology advances, ethical considerations, legal frameworks, and social understanding are required regarding the impact on human society and the natural environment.<br>
                    Ethical issues involve how technology should be used, considering its effects on life and the environment. For example, the use of genetic modification or AI technologies is debated in terms of whether it contradicts bioethics, and whether technology affects human dignity or freedom.<br>
                    &nbsp;&nbsp;&nbsp;&nbsp;Legal issues call for the establishment of legal frameworks to protect risks and rights associated with new technologies. Laws must be developed from various perspectives, such as intellectual property rights, patents, security regulations, and data protection, to prevent misuse or harm.<br>
                    &nbsp;&nbsp;&nbsp;&nbsp;Social issues require that, beyond researchers, many people understand the impact of technological advancements on society. Reliable information must be disseminated to prevent fears and misconceptions, and through various policies and education, social acceptability must be raised. It is also important to ensure that new technologies do not exacerbate social inequalities and that fairness and equality are maintained.<br>
                    &nbsp;&nbsp;&nbsp;&nbsp;By utilizing science and technology from the ELSI perspective, we can ensure that technology is used sustainably and safely in human society, establishing clear criteria for what value it creates for humanity or society, and what it brings.</p>

                <h4>DNA Origami</h4>
                    <p>&nbsp;&nbsp;&nbsp;&nbsp;ELSI in DNA origami technology is crucial to balance the new possibilities it offers with the accompanying risks. DNA origami is expected to have wide applications, from medicine to the environment, and while it offers innovative solutions, it also poses risks of unintended effects or misuse on the human body or the environment.<br>
                    &nbsp;&nbsp;&nbsp;&nbsp;Specifically, to ensure the technology integrates safely and fairly into society, ethical aspects (such as safety and the ethics of life manipulation), legal frameworks (clarifying patents and regulations), and social issues (education and equitable access) must be comprehensively considered. Careful consideration of ELSI will enhance the reliability and public understanding of DNA origami, contributing to the realization of a society where the benefits of the technology are shared fairly.</p>

            <div class="topic-title text-center"><h2>ELSI challenges of "Nano Pill Bug"</h2></div>
                <p>&nbsp;&nbsp;&nbsp;&nbsp;Looking at our project from an ELSI perspective, we see many challenges.</p>
                <p>&nbsp;&nbsp;&nbsp;&nbsp;Although it may not be a direct solution, the following is an evaluation of “NanoPillBug” and DNAorigami from the ELSI's point of view, broken down by Ethics, Legal, and Social.</p>

            <div class="topic-title"><h3>1. Ethical Issue</h3></div>
                <h4>1.1 Safety in Medical Applications</h4>
                    <p>&nbsp;&nbsp;&nbsp;&nbsp;In developing medical technologies using DNA origami, it is important to understand how DNA origami functions within the body and its effects on the immune and metabolic systems. The process by which the "Nano Pill Bug" captures and protects miRNA in vivo, and the potential for undesirable side effects or immune reactions as it is transported in the blood, must be long-term evaluated.</p>
                <h4>1.2 Ethics of Genetic Manipulation and Biotechnology</h4>
                    <p>&nbsp;&nbsp;&nbsp;&nbsp;DNA origami enables advanced manipulation of cells and molecules, so the ethical boundaries of life science must be carefully discussed. The "Nano Pill Bug" is a nanoscale molecular robot, meaning it does not directly attack cells, but by interacting with miRNA involved in the central dogma, it could potentially cause unintended genetic mutations.</p>
                <h4>1.3 Environmental Impact</h4>
                    <p>&nbsp;&nbsp;&nbsp;&nbsp;When DNA origami is used in medicine or environmental restoration, consideration of its impact on the natural environment if released into nature is necessary. While it is biodegradable, there is still the risk of unintended effects on ecosystems. In implementing the "Nano Pill Bug," methods for collection and diagnosis must be devised, as well as plans for post-treatment and disposal.</p>
                <h4>1.4 Dual-use Issue</h4>
                    <p>&nbsp;&nbsp;&nbsp;&nbsp;Dual-use refers to technology that can be used for both civilian and military purposes. DNA origami also carries the risk of being diverted into biological weapons or harmful substances. Therefore, proper understanding and use of this technology is essential, and stringent ethical standards and regulations are necessary in its development, sharing, and management.</p>
                <h4>1.5 Privacy and Protection of Personal Data</h4>
                    <p>&nbsp;&nbsp;&nbsp;&nbsp;When using the "Nano Pill Bug" in medical diagnostics, patient genetic information and biological data are essential. How this data is handled and protected is an important ethical issue. It is crucial to ensure the safety and privacy of the data, preventing leakage or misuse of personal information.</p>

            <div class="topic-title"><h3>2. Legal Issue</h3></div>
                <h4>2.1 Regulatory Framework</h4>
                    <p>&nbsp;&nbsp;&nbsp;&nbsp;DNA origami has applications in the medical and biotechnology fields, and regulations to ensure its safety for the human body and the environment are essential. However, since DNA origami technology is new, existing regulatory frameworks may not be sufficient. Clear guidelines and standards for handling nanostructures like DNA origami in medical devices and pharmaceuticals are necessary.</p>
                <h4>2.2 Security</h4>
                    <p>&nbsp;&nbsp;&nbsp;&nbsp;DNA origami technology carries the risk of being misused as biological weapons or harmful substances, necessitating laws for safety management and monitoring. In addition, researchers and companies handling DNA origami must implement strict security measures to prevent unauthorized access to sensitive information.</p>
                <h4>2.3 International Regulatory Coordination</h4>
                    <p>&nbsp;&nbsp;&nbsp;&nbsp;As DNA origami research and applications are conducted internationally, differences in regulations and safety standards between countries can hinder the spread of the technology and international cooperation. For example, if DNA origami technology is approved in one country but banned in another, this could restrict technology transfer and collaborative research. Therefore, international agreements and guidelines are necessary.</p>
                <h4>2.4 Intellectual Property and Patents</h4>
                    <p>&nbsp;&nbsp;&nbsp;&nbsp;Since DNA origami is a new field within nanotechnology, there are ambiguous areas regarding patent rights and intellectual property. When the design of DNA structures or specific assembly methods are protected by patents, it could restrict development and use, making it difficult for other researchers or companies to access the technology. On the other hand, if patents are not granted, ethical issues may arise if harm occurs and accountability is unclear. Additionally, as patents are managed under different laws in various regions and countries, international protection of intellectual property remains a challenge.</p>
                <h4>2.5 Privacy Protection and Handling of Biodata</h4>
                    <p>&nbsp;&nbsp;&nbsp;&nbsp;When DNA origami is applied in personalized medicine, patient genetic information and medical data are essential. Legal protection is required for how such data is collected, stored, and used. In particular, robust privacy protection laws and data management regulations are needed to prevent data leakage or misuse.</p>

            <div class="topic-title"><h3>3. Social Issue</h3></div>
                <h4>3.1 Understanding and Acceptance of Technology</h4>
                    <p>&nbsp;&nbsp;&nbsp;&nbsp;Since DNA origami is an advanced biotechnology, it may be difficult for the general public to understand how it works, its benefits, and its risks. This may lead to anxiety or misunderstandings about DNA origami, affecting its social acceptance. Additionally, there is a risk that dishonest individuals could exploit innocent people who do not understand the technology. In the medical field, education and information dissemination are critical to gaining patient and consumer trust.</p>
                <h4>3.2 Education and Human Resource Development</h4>
                    <p>&nbsp;&nbsp;&nbsp;&nbsp;The development of DNA origami technology requires experts familiar with nanotechnology and molecular biology. Given the current shortage of professionals who can understand and apply this advanced technology, it is urgent to develop educational programs to cultivate talent in this field. Specifically, programs that enable the next generation of scientists and engineers to learn both foundational and specialized skills are necessary.</p>
                <h4>3.3 Inequality and Unequal Access</h4>
                    <p>&nbsp;&nbsp;&nbsp;&nbsp;DNA origami has the potential to bring significant benefits to medicine and environmental fields, but there is a risk that advanced countries or the wealthy will enjoy these benefits first, while developing countries or lower-income populations are left behind. Unequal access to such technology may exacerbate social disparities, and public policies or subsidy systems should promote equal utilization.</p>
                <h4>3.4 Social Discussion on Ethical Concerns</h4>
                    <p>&nbsp;&nbsp;&nbsp;&nbsp;In the medical and environmental applications of DNA origami, ethical issues are closely tied to concerns about genetic manipulation and artificial life operations. There is growing concern about how these technologies affect society and the natural balance. It is important for society as a whole to openly discuss these ethical aspects and form a consensus on the use of the technology.</p>

            <div class="section s_06">
                <div class="accordion_one">
                    <div class="accordion_header" id="ac1_b">REFERENCES<div class="i_box"><i class="one_i"></i></div></div>
                    <div class="accordion_inner">
                        <div class="box_one">

                            <ul>
                                <li>
                                    <strong>National Human Genome Research Institute.</strong> 2024. The Human Genome Project. Available at: <a href="https://www.genome.gov/human-genome-project">https://www.genome.gov/human-genome-project</a>
                                </li>
                                <li>
                                    <strong>Cabinet Office, Government of Japan. </strong> 2024. The 5th Science and Technology Basic Plan. Available at: <a href="https://www8.cao.go.jp/cstp/kihonkeikaku/index5.html">https://www8.cao.go.jp/cstp/kihonkeikaku/index5.html</a>
                                </li>
                                <li>
                                    <strong>Kim, T. & Croce, C.M.</strong> 2023. MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies. Experimental & Molecular Medicine, 55, pp. 1314-1321.
                                </li>
                                <li>
                                    <strong>Iorio MV, Croce CM.</strong> MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol. 2009 Dec 1;27(34):5848-56. doi: 10.1200/JCO.2009.24.0317. Epub 2009 Nov 2. PMID: 19884536; PMCID: PMC2793003.
                                </li>
                                <li>
                                    <strong>Lee RC, Feinbaum RL, Ambros V.</strong> The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993 Dec 3;75(5):843-54. doi: 10.1016/0092-8674(93)90529-y. PMID: 8252621.
                                </li>
                                <li>
                                    <strong>Wightman B, Ha I, Ruvkun G.</strong> Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell. 1993 Dec 3;75(5):855-62. doi: 10.1016/0092-8674(93)90530-4. PMID: 8252622.
                                </li>
                                <li>
                                    <strong>Pasquinelli, A.E., Reinhart, B.J., Slack, F., et al.</strong> 2000. Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature, 408, pp. 86-89.
                                </li>
                            </ul>                        

                        </div>
                    </div>
                    <div class="closeArea">
                        <div class="close_box"><a href="#ac1_b" class="close_btn">Close<div class="i_box"><i class="one_i"></i></div></a></div>
                    </div>
                </div>
            </div>
        </section>
        </main>
        </div>
    </div>

    <!-- JS -->
    <script src="https://code.jquery.com/jquery-3.7.0.min.js"></script>
    <script src="https://t2biomod2024.github.io/2024/JS/common.js"></script>
    <script src="https://cdnjs.cloudflare.com/ajax/libs/protonet-jquery.inview/1.1.2/jquery.inview.min.js"></script>
    <script src="https://t2biomod2024.github.io/2024/JS/jquery_inview.js"></script>
    <script src="https://t2biomod2024.github.io/2024/JS/bootstrap.min.js"></script>
    <script src="https://t2biomod2024.github.io/2024/JS/main.js"></script>
</body>
</html>